Friday, April 12, 2024 12:02:34 AM
well that and a possible reverse split with a move over to nasdaq coinciding with a good amount of dilution...and maybe doing some deals that some may not like or with entities spome may not like...
i dont know how India does business, but they may prefer a situation where the ceo / founder has full control and really cant be contested...especially if they are going to invest money or do the buyout...
something like that might light a fire under the US gov or military's butt...they would need to get off their ass and start making things happen or lose out...
how about in the case of a buyout, a bidding war starts between dupont and India's Tata..
theres all kinds of possibilities that could come up that would require swift moves and approvals....at least on the OTC...on nasdaq, it'll be much harder...actual shareholder meetings will be required as well as a BOD...he can have all the shares and votes that he wants, but it will be harder for him to have his way...
im not opposed to a r/s as long as we are at one buck or more and it means a move over to nasdaq...nor would i be against a reasonable amount of dilution at that time...
if we are on nasdaq at 10 bucks a share, mass producing, selling product, generating revenue, being marketed and becoming known, then the r/s and dilution would be offset by the increased investments from institutions and large investors....
yea i know im all over the place, but i see all these things as possibilities...many of them are probabilities...and while they present certain problems, they are good problems to have to deal with...
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM